Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.506
https://www.valueinhealthjournal.com/article/S1098-3015(16)31873-3/fulltext
Title :
Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31873-3&doi=10.1016/j.jval.2016.09.506
First page :
A434
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
478